---
figid: PMC4522054__12872_2015_74_Fig1_HTML
figtitle: Conceptual model of general health factors, salient CHD pathogenetic pathways
  and CHD hallmarks
organisms:
- Porphyromonas gingivalis
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4522054
filename: 12872_2015_74_Fig1_HTML.jpg
figlink: /pmc/articles/PMC4522054/figure/Fig1/
number: F1
caption: Conceptual model of general health factors, salient CHD pathogenetic pathways
  and CHD hallmarks. Note. From “How do high glycemic load diets influence coronary
  heart disease?” by Mathews M, Liebenberg L, Mathews EH Nutr Metab 2015;12:6 [].
  The affective pathway of pharmacotherapeutics, boxes, is shown in Fig. 1, and salient
  serological biomarkers are indicated by tags (). The blunted arrows denote antagonize
  or inhibit and pointed arrows denote up-regulate or facilitate. ACE denotes angiotensin-converting-enzyme;
  BDNF, brain-derived neurotrophic factor; β-blocker, beta-adrenergic antagonists;
  BNP, B-type natriuretic peptide; COX, cyclooxygenase; CRP, C-reactive protein; D-dimer,
  fibrin degradation product D; FFA, free fatty acids; GCF, gingival crevicular fluid;
  HDL, high-density lipoprotein; HbA1c, glycated hemoglobin A1c; Hs, homocysteine;
  ICAM, intracellular adhesion molecule; IGF-1, insulin-like growth factor-1; IL,
  interleukin; LDL, low-density lipoprotein; MAPK, mitogen-activated protein (MAP)
  kinase; MCP, monocyte chemoattractant protein; MIF, macrophage migration inhibitory
  factor; MMP, matrix metalloproteinase; MPO, myeloperoxidase; NFκβ, nuclear factor-κβ;
  NLRP3, Inflammasome responsible for activation of inflammatory processes as well
  as epithelial cell regeneration and microflora; NO, nitric oxide; NO-NSAIDs, combinational
  NO-non-steroidal anti-inflammatory drug; OPG, osteoprotegerin; oxLDL, oxidized LDL;
  P. gingivalis, Porphyromonas gingivalis; PAI, plasminogen activator inhibitor; PDGF,
  platelet-derived growth factor; PI3K, phosphatidylinositol 3-kinase; RANKL, receptor
  activator of nuclear factor kappa-beta ligand; ROS, reactive oxygen species; SCD-40,
  recombinant human sCD40 ligand; SMC, smooth muscle cell; SSRI, serotonin reuptake
  inhibitors; TF, tissue factor; TMAO, an oxidation product of trimethylamine (TMA);
  TNF-α , tumor necrosis factor-α; vWF, von Willebrand factor; VCAM, vascular cell
  adhesion molecule
papertitle: The mechanisms by which antidepressants may reduce coronary heart disease
  risk.
reftext: Marc J. Mathews, et al. BMC Cardiovasc Disord. 2015;15:82.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9405134
figid_alias: PMC4522054__F1
figtype: Figure
redirect_from: /figures/PMC4522054__F1
ndex: a09ccf59-decb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4522054__12872_2015_74_Fig1_HTML.html
  '@type': Dataset
  description: Conceptual model of general health factors, salient CHD pathogenetic
    pathways and CHD hallmarks. Note. From “How do high glycemic load diets influence
    coronary heart disease?” by Mathews M, Liebenberg L, Mathews EH Nutr Metab 2015;12:6
    []. The affective pathway of pharmacotherapeutics, boxes, is shown in Fig. 1,
    and salient serological biomarkers are indicated by tags (). The blunted arrows
    denote antagonize or inhibit and pointed arrows denote up-regulate or facilitate.
    ACE denotes angiotensin-converting-enzyme; BDNF, brain-derived neurotrophic factor;
    β-blocker, beta-adrenergic antagonists; BNP, B-type natriuretic peptide; COX,
    cyclooxygenase; CRP, C-reactive protein; D-dimer, fibrin degradation product D;
    FFA, free fatty acids; GCF, gingival crevicular fluid; HDL, high-density lipoprotein;
    HbA1c, glycated hemoglobin A1c; Hs, homocysteine; ICAM, intracellular adhesion
    molecule; IGF-1, insulin-like growth factor-1; IL, interleukin; LDL, low-density
    lipoprotein; MAPK, mitogen-activated protein (MAP) kinase; MCP, monocyte chemoattractant
    protein; MIF, macrophage migration inhibitory factor; MMP, matrix metalloproteinase;
    MPO, myeloperoxidase; NFκβ, nuclear factor-κβ; NLRP3, Inflammasome responsible
    for activation of inflammatory processes as well as epithelial cell regeneration
    and microflora; NO, nitric oxide; NO-NSAIDs, combinational NO-non-steroidal anti-inflammatory
    drug; OPG, osteoprotegerin; oxLDL, oxidized LDL; P. gingivalis, Porphyromonas
    gingivalis; PAI, plasminogen activator inhibitor; PDGF, platelet-derived growth
    factor; PI3K, phosphatidylinositol 3-kinase; RANKL, receptor activator of nuclear
    factor kappa-beta ligand; ROS, reactive oxygen species; SCD-40, recombinant human
    sCD40 ligand; SMC, smooth muscle cell; SSRI, serotonin reuptake inhibitors; TF,
    tissue factor; TMAO, an oxidation product of trimethylamine (TMA); TNF-α , tumor necrosis
    factor-α; vWF, von Willebrand factor; VCAM, vascular cell adhesion molecule
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CRP
  - CSRP1
  - PPIAP10
  - AOPEP
  - IGKV2-28
  - NES
  - IL6
  - RORC
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MIF
  - AMH
  - S100A8
  - S100A9
  - CCL2
  - SELE
  - SELL
  - SELP
  - SERPINE1
  - TF
  - EFS
  - POLR3E
  - TNFSF11
  - VCAM1
  - ICAM1
  - ICAM2
  - ICAM3
  - ICAM4
  - ICAM5
  - DYM
  - ACE
  - EYA1
  - CDCA8
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - TNNC1
  - TNNC2
  - TNNI1
  - TNNI2
  - TNNI3
  - TNNT1
  - TNNT2
  - TNNT3
  - IGF1
  - DELYQ11
  - MPO
  - Orai
  - crp
  - Drs
  - apo
  - tha
  - ned
  - es
  - nes
  - modSP
  - lin
  - drl
  - Or43a
  - tor
  - Tor
  - Egfr
  - et
  - tc
  - MKP-4
  - p38b
  - rl
  - tf
  - Polr3E
  - by
  - snRNP-U1-C
  - Ace
  - Acer
  - Ance
  - bor
  - borr
  - Dif
  - dl
  - Rel
  - Scox
  - sna
  - se
  - TMAO
  - Statine
  - Choline
  - glucose
  - Cortisol
  - Serotonin
---
